You can find the annual or quarterly income statement of Faeth Therapeutics Ord Shs here for insights into the performance and operational efficiency of Faeth Therapeutics Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating expenses
--37.67M
R&D expenses
--17.96M
Depreciation, depletion, and amortization
--30.00K
Operating profit
---37.67M
Net non-operating interest income (expenses)
Non-operating interest income
--392.00K
Special income (expenses)
---132.96M
Other non-operating income (expenses)
--1.00K
Income before tax
---170.23M
Income tax
--0.00
Income after tax
---170.23M
Net income from continuous operations
---170.23M
Net income attributable to controlling interests
---170.24M
Net income attributable to common shareholders
---170.24M
Basic earnings per share
---131.45
Diluted earnings per share
---131.45
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.